Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Profit After Tax came in at -$4.4 million in Q1 2026, down 7.27% year-over-year from -$4.7 million in Q1 2025, and up 33.28% quarter-over-quarter from -$6.5 million in Q4 2025.
Analysis
Incannex Healthcare (IXHL) Profit After Tax (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Profit After Tax across 5 years of filings, most recently posting -$4.4 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 7.27% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at -$48.7 million (down 126.55% YoY), while the FY2025 annual figure was -$46.9 million, down 152.94% from the prior year.
- Profit After Tax came in at -$4.4 million for Q1 2026 at Incannex Healthcare, up from -$6.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$1.2 million in Q3 2023 to a low of -$31.4 million in Q2 2025.
- Average Profit After Tax over 5 years is -$7.0 million, with a median of -$5.7 million recorded in 2024.
- The largest YoY upside for Profit After Tax was 40.8% in 2025 against a maximum downside of 412.47% in 2025.
- Over 5 years, Profit After Tax stood at -$2.9 million in 2022, then plunged by 79.61% to -$5.2 million in 2023, then fell by 12.46% to -$5.9 million in 2024, then decreased by 10.64% to -$6.5 million in 2025, then jumped by 33.28% to -$4.4 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$4.4 million in Q1 2026, -$6.5 million in Q4 2025, and -$6.4 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -248.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 438.21 Mn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | -4.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -4.35 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.44 Mn |
| Mar 31, 2025 | -4.06 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.14 Mn |
| Mar 31, 2024 | -6.85 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -1.24 Mn |
| Jun 30, 2023 | -7.75 Mn |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -2.92 Mn |